BRIEF published on 04/07/2026 at 11:10, 28 days 17 hours ago Virbac: Declaration on voting rights as of March 31, 2026 Voting Rights Euronext Actions Finance VIRBAC
PRESS RELEASE published on 03/17/2026 at 19:00, 1 month 19 days ago Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2025
BRIEF published on 12/16/2025 at 09:58, 4 months 20 days ago Virbac acquires Thyronorm for the treatment of feline hyperthyroidism Acquisition Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
BRIEF published on 12/16/2025 at 09:58, 4 months 20 days ago Virbac Acquires Thyronorm to Combat Feline Hyperthyroidism Veterinary Medicine Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
PRESS RELEASE published on 12/16/2025 at 09:53, 4 months 20 days ago VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm Virbac acquires innovative drug Thyronorm from Norbrook to stabilize feline hyperthyroidism, expanding distribution in key markets and enhancing senior cats' quality of life Acquisition Feline Hyperthyroidism VIRBAC Thyronorm Senior Cats
BRIEF published on 11/07/2025 at 15:44, 5 months 28 days ago Virbac: Update on shares and voting rights Euronext Paris Voting Rights Actions Transparency VIRBAC
BRIEF published on 09/12/2025 at 17:50, 7 months 23 days ago Virbac Reports Solid Growth in 2025 First Half Results Revenue Growth Operating Income VIRBAC 2025 Forecast Global Market Performance
PRESS RELEASE published on 09/12/2025 at 17:45, 7 months 23 days ago Virbac: 2025 Half-year results Virbac reports solid revenue growth of 5.6% in the first half of 2025, meeting adjusted operating income expectations. Targets for 2025 confirmed with revenue growth of 4-6% expected Financial Results Revenue Growth Operating Income VIRBAC Targets Confirmed
BRIEF published on 08/18/2025 at 09:35, 8 months 18 days ago Virbac reveals the remuneration of its new CEO General Manager Remuneration VIRBAC Free Shares Paul Martingell
PRESS RELEASE published on 08/18/2025 at 09:30, 8 months 18 days ago Virbac:: Paul Martingell's compensation terms Virbac's board of directors approves compensation terms for Paul Martingell as CEO, including fixed and variable components, long-term incentives, and exceptional benefits Board Of Directors CEO VIRBAC Paul Martingell Compensation Terms
Published on 05/06/2026 at 02:17, 2 hours 7 minutes ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 2 hours 24 minutes ago Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 2 hours 24 minutes ago Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 01:30, 2 hours 54 minutes ago Presentation to RIU Sydney Resources Roundup
Published on 05/06/2026 at 01:20, 3 hours 4 minutes ago Empress Grants Stock Options and Equity Incentives
Published on 05/06/2026 at 03:05, 1 hour 18 minutes ago ARC Group Advises Magnax on €35.5 Million Strategic Investment from Pan-International Industrial Corp. and Foxconn Group
Published on 05/06/2026 at 03:05, 1 hour 18 minutes ago Bank of America Convenes Global Leaders in Asia Pacific for its Breakthrough Technology Dialogue
Published on 05/06/2026 at 01:35, 2 hours 48 minutes ago VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING
Published on 05/06/2026 at 00:05, 4 hours 18 minutes ago ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds
Published on 05/05/2026 at 23:05, 5 hours 18 minutes ago Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
Published on 05/05/2026 at 19:00, 9 hours 24 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 18:03, 10 hours 20 minutes ago Aéroports de Paris SA - Shares and voting rights as of 30 April 2026
Published on 05/05/2026 at 17:53, 10 hours 30 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - April 2026
